Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Rhoifolin is a flavonoid glycoside that has been found in C. nudiflora and has diverse biological activities.1,2,3,4,5 It inhibits Ezrin phosphorylation, cell migration, and TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in MDA-MB-231 cells when used at concentrations of 10 and 40 µM.1 Rhoifolin inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), also known as 3C-like protease (3CLpro; IC50 = 27.45 µM).2 It reverses scopolamine-induced memory deficits and inhibits acetylcholinesterase (AChE) activity in zebrafish when administered in the tank water at concentrations of 1, 3, and 5 µg/L.3 Rhoifolin (20 and 40 mg/kg) reduces paw edema and IL-1β, IL-6, and TNF-α levels in a rat model of carrageenan-induced inflammation.4 It also ameliorates cartilage damage in a rat model of osteoarthritis, an effect that can be reversed by the autophagy inhibitor 3-methyladenine (Item No. 13242).5
WARNING This product is not for human or veterinary use.
1. In vitro anti-
2. Inhibition of SARS-
3. Ameliorative effects of rhoifolin in scopolamine-
4. Rhoifolin alleviates inflammation of acute inflammation animal models and LPS-
5. Rhoifolin ameliorates osteoarthritis via regulating autophagy. Front. Pharmacol. 12, 661072 (2021).